Delcath Expands Multi-Center Phase III Trial for Metastatic Melanoma June 24, 2008 Yahoo! Finance News in Canada and several other news sources, June 24, 2008 UTMB's Dr. Orhan Ozkan is the principal investigator for a new device for treating inoperable liver cancer that is being tested at six cancer treatment centers. Ozkan commented, "We are excited about being a part of this clinical trial and being the first center to offer this treatment modality to patients in this region of the US." A similar report is also on CNNMoney.com http://money.cnn.com/news/newsfeeds/articles/marketwire/0409740.htm « Back | The Newsroom »